91破解版

Ph.D. 1991
University of Minnesota, Minneapolis, MN

MS 1983
Univiversity of Cincinnati, Cincinnati, OH

BS 1981
National University of Athens, Greece

Targeted drug delivery to cancer. Physicochemical evaluation and formulation of pharmaceuticals, drug delivery systems including aerosols and dermatologicals. Studies on the interaction of proteins with lipid membranes.

Lambros M, Moreno J, Fei Q, Parsa C, Orlando R, Van Haute L. . International Journal of Molecular Sciences, 24(5):5058, 2023.

Dash, A, K., and Lambros MP, 鈥淢embrane Transport鈥� in Pharmaceutics: Basic Principles and Application to Pharmacy Practice. Dash, A. K., Singh, S., Editors, 2st Edition, London, Elsevier, September 2023.

Lambros, M. Thac, Fei, Q., Nicolaou, M., 鈥溾��, Pharmaceutics, 14 (5), 972, 2022.

Ashley, D., Hernandez, J., Cao, R., To, K., Yeglarzaryan, A., Abrahem, R., Nguyen, T., Owens, J., Lambros, M., Subbian, S., Venketaraman, V., 鈥淎ntimycobacterial Effects of Everolimus in a Human Granuloma Model鈥�, J. Clin. Medicine, 2020, doi:10.3390/jcm9072043

Lambros, M, Huang, Y, Mulamalla, HC, Patent 鈥溾�� Patent no 9808425.

Fei Q, Kent D, Botello-Smith WM, Nur F, Nur S, Alsamarah A, Chatterjee P, Lambros M, Luo Y. Molecular Mechanism of Resveratrol鈥檚 Lipid Membrane Protection. Scientific Reports. 2018;8.

Moreno, J. A., Sanchez, A., Hoffman, R. M., Nur, S., Lambros, M. P. Fluorescent Orthotopic Mouse Model of Pancreatic Cancer.J. Vis. Exp.(115), e54337, 2016,doi:10.3791/54337

Lambros, M. P., M. K. DeSalvo, H. C. Mulamalla, J. Moreno,and L. Kondapalli. " Genomics Data, 7: 137-139, 2016.

Lambros, MP, DeSalvo, MK, Moreno, J, Mulamalla, HC, Kondapalli, L., 鈥溾��, Genomics Data, 6:40-43, 2015.

Lambros, MP, Kondapalli, L, Parsa, C, Mulamalla, HC, Orlando, R, Pon, D, Huang, Chow, MSS., 鈥溾��, Evidence-Based Complementary and Alternative Medicine, Article ID 425760, 2015.

Lambros, MP, Beringer, P, Wong-Beringer, A., 鈥淣ebulizer Choice Affects the Airway Targeting of Amphotericin B Lipid Complex Aerosols鈥�, J Pharm Tec. 29:199-205, 2013

Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, Massie A, Smolders I, Methner A, Pergande M, Smith SB, Ganapathy V, Maher P. The Cystine/Glutamate Antiporter System x(c)(-) in Health and Disease: From Molecular Mechanisms to Novel Therapeutic Opportunities. . Antioxid Redox Signal, 2012 Aug 3. [Epub ahead of print] PubMed PMID: 22667998.

Lambros, MP., Parsa, C., Mulamalla, HC., Orlando, R., Lau, B., Pon, D., Chow, M., 鈥淚dentifying Cell and Molecular Stress After Irradiation in a Three Dimensional (3-D) Model of Oral Mucositis鈥� Biochemical and Biophysica Research Communications, 405:102-106, 2011.

Wong Beringer, A., Polikandritou Lambros, M., Beringer, P., Johnson D.L., 鈥淪uitability of Caspofungin for Prevention of Pulmonary Aspergillosis: Physicochemical Profiling and Nebulizer Choice鈥� Chest, 128:3711-3716, 2005.

Polikandritou Lambros, M. and Y. E. Rahman "Effect of A Polypeptide on Model Lipid Membranes" Chemistry and Physics of Lipids 131: 63-69, 2004.

Polikandritou Lambros, M. Abbas, S.A., Dunn T., Raja, T., and Pento, "Targeting Hepatocytes with Liposomal Interferon alpha: "Effect on Metallothionein Gene Induction" Research Communications in Molecular Pathology and Pharmacology, 112:50-58, 2002.

Abang, A. M., Abbas, S.A., Pham, T., Polikandritou Lambros, M. "A New HPLC Method for Fludarabine and Fludarabine Phosphate Compounded in Liposomes" International Journal of Pharmaceutical Compounding, 5:320-322, 2001

Polikandritou Lambros, M., Schafer, F., Blackstock, R., and Murphy, J. W., "Liposomes, a Potential Immunoadjuvant and Carrier for a Cryptococcal Vaccine" J. Pharm. Sci., 87:1144-1148, 1998.

Polikandritou Lambros, M., Sheu, Y. L., and Pereira, H. A., "Interaction of a Synthetic Peptide Based on the Neutrophil-Derived Antimicrobial Protein CAP-37 with Dipalmitoyl-Phosphatidylcholine Membranes", Biochim. Biophys. Acta, 1329:285-290, 1997